Atlas Trials

Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension

Clinical trial NCT00219037 · COMPLETED

Trial details

NCT number
NCT00219037
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2004-06-01
Primary completion
2005-10-01
Enrollment
1955

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.